Impact of Grenfell Tower fire disaster on polyisocyanurate industry.

Autor: Mitchener, Grazyna

Publikováno v: Polimery; 2018, Vol. 63 Issue 10, p716-722, 7p

Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.

Autor: Ahmed SK; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Haese NN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Cowan JT; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Pathak V; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Moukha-Chafiq O; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Smith VJ; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Rodzinak KJ; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Ahmad F; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Zhang S; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Bonin KM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Streblow AD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Streblow CE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Morrison C; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Sarkar S; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Moorman N; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Sander W; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Allen R; Oregon Translational Research and Development Institute, Portland, Oregon 97239, United States., DeFilippis V; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Tekwani BL; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Wu M; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Hirsch AJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Smith JL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Tower NA; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Rasmussen L; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Bostwick R; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Maddry JA; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Ananthan S; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Gerdes JM; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Augelli-Szafran CE; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Suto MJ; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States., Morrison TE; Department of Immunology and Microbiology, University of Colorado School of Medicine, 12800 E. 19th Avenue, Aurora, Colorado 80045, United States., Heise MT; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States., Pathak AK; Drug Discovery Division, Southern Research, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2021 Apr 22; Vol. 64 (8), pp. 4762-4786. Date of Electronic Publication: 2021 Apr 09.

Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.

Autor: Nguyen TH; Chemistry Department, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Haese NN; Vaccine and Gene Therapy Institute , Oregon Health & Science University , 505 NW 185th Avenue , Beaverton , Oregon 97006 , United States., Madadi N; Chemistry Department, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Sarkar S; Department of Genetics , University of North Carolina School of Medicine , Chapel Hill , North Carolina 27599 , United States., Bonin K; Vaccine and Gene Therapy Institute , Oregon Health & Science University , 505 NW 185th Avenue , Beaverton , Oregon 97006 , United States., Streblow CE; Vaccine and Gene Therapy Institute , Oregon Health & Science University , 505 NW 185th Avenue , Beaverton , Oregon 97006 , United States., Taft-Benz S; Department of Genetics , University of North Carolina School of Medicine , Chapel Hill , North Carolina 27599 , United States., Tower NA; High-Throughput Screening Center, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Rasmussen L; High-Throughput Screening Center, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Bostwick R; High-Throughput Screening Center, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Augelli-Szafran CE; Chemistry Department, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Suto MJ; Chemistry Department, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States., Morrison TE; Department of Immunology and Microbiology , University of Colorado School of Medicine , 12800 E. 19th Avenue , Aurora , Colorado 80045 , United States., DeFilippis V; Vaccine and Gene Therapy Institute , Oregon Health & Science University , 505 NW 185th Avenue , Beaverton , Oregon 97006 , United States., Heise MT; Department of Genetics , University of North Carolina School of Medicine , Chapel Hill , North Carolina 27599 , United States., Streblow DN; Vaccine and Gene Therapy Institute , Oregon Health & Science University , 505 NW 185th Avenue , Beaverton , Oregon 97006 , United States., Pathak AK; Chemistry Department, Drug Discovery Division , Southern Research , 2000 Ninth Avenue South , Birmingham , Alabama 35205 , United States.

Publikováno v: ACS infectious diseases [ACS Infect Dis] 2019 Dec 13; Vol. 5 (12), pp. 2014-2028. Date of Electronic Publication: 2019 Jul 11.

Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.

Autor: Schroeder CE; University of Kansas Specialized Chemistry Center , Lawrence, Kansas 66049, United States., Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2014 Oct 23; Vol. 57 (20), pp. 8608-21. Date of Electronic Publication: 2014 Oct 07.

Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.

Autor: Chung DH; Departments of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, United States of America; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America., Jonsson CB; Departments of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, United States of America; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America; Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, United States of America., Tower NA; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., Chu YK; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America., Sahin E; Departments of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, United States of America; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America., Golden JE; University of Kansas Specialized Chemistry Center, Lawrence, Kansas, United States of America., Noah JW; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., Schroeder CE; University of Kansas Specialized Chemistry Center, Lawrence, Kansas, United States of America., Sotsky JB; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America., Sosa MI; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., Cramer DE; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, Kentucky, United States of America., McKellip SN; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., Rasmussen L; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., White EL; Drug Discovery Department, Southern Research Institute, Birmingham, Alabama, United States of America., Schmaljohn CS; The United States Army Medical Research Institute for Infectious Diseases, Ft. Detrick, Maryland, United States of America., Julander JG; Institute for Antiviral Research, Utah State University, Logan, Utah, United States of America., Smith JM; The United States Army Medical Research Institute for Infectious Diseases, Ft. Detrick, Maryland, United States of America., Filone CM; Boston University, Boston, Massachusetts, United States of America., Connor JH; Boston University, Boston, Massachusetts, United States of America., Sakurai Y; Texas Biomedical Research Institute, San Antonio, Texas, United States of America., Davey RA; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2014 Jun 26; Vol. 10 (6), pp. e1004213. Date of Electronic Publication: 2014 Jun 26 (Print Publication: 2014).